All News

Recent cases of flesh-eating bacteria infections are surfacing from Florida waters, which may be due to climate change.

Prequalification tells global funders and Ministries of Health that the product meets global standards of quality, safety, and performance.

STRAND and OmniSYS share a passion for leveraging the pharmacy setting to improve patient outcomes, according to a company executive.

Granted FDA approval in 2018, this product was made available in hospitals and clinics earlier this year.

There are currently an estimated 8.1 million males and 8.8 million females in the United States with a history of cancer.

A protein called DDX3X has been found to regulate a melanoma-specific oncogene called MITF that is central to the development of the pigment cells in the skin.

Top news of the day from across the health care landscape.

The nature of pharmacy reimbursement in changing, shifting from the standard fee-for-service, 'fill-and-bill' model to a patient-centric, value-based system. However, the transition between these 2 means of revenue is often confusing and frustrating for independent pharmacists.

Due to the large number of people affected, chlamydia has become a global health concern.

A recent study analyzed the 10-year absolute risks of thromboembolism and bleeding in patients with a history of hematologic cancer.

Top news of the day from across the health care landscape.

A new study of patients treated with ophthalmology medications indicates that electronic health records may not contain accurate, up-to-date information.

CDc11+ dendritic cells are the first to interact with HIV and transmit the virus to other cells in the body.

Retina Risk is a new app that patients can use to help screen for their risk of retinopathy.

Patients with psoriasis reported frequent use of complementary or alternative medicine, but less than half said they would recommend these therapies to others.

The AOA recommends that prescribers not argue with their patients who may be against vaccinations, but instead, provide information and resources on the benefits and remain as a resource for any potential questions.

As young patients with bone cancer are often treated with high doses of chemotherapy before and after surgery, researchers wanted to develop gentler treatment options.

Selinexor (Xpovio, Karyopharm) tablets in combination with the corticosteroid dexamethasone was approved under the agency's accelerated approval program.

Selinexor (Xpovio, Karyopharm) received approval in combination with dexamethasone for heavily-pretreated patients with relapsed or refractory multiple myeloma.

Three new studies looked at the mechanisms involved in tissue damage related to rheumatoid arthritis and lupus.

FOXA1 has been previously known to be mutated in prostate cancer; however, its biological functions were not understood well.

One company, LogicStream Health, creates software that integrates with a hospital EHR system for multiple platform services.

Top news of the day from across the health care landscape.

Health care professionals, including pharmacists and nurse practitioners, play a critical role in attaining goals for reducing HIV transmission.

Drug shortages can adversely affect patient care in the community and hospital settings.

Aptevo Therapeutics announced the launch of its new vial size for its coagulation factor IX recombinant (Ixinity) treatment for hemophilia B in the US market.

A recent study showed that adherence to prophylaxis for severe hemophilia A can improve a patient’s physical performance.

Top news of the day from across the health care landscape.